The Q1 2026 filing reveals a company in the midst of a high-stakes transformation. On one hand, the operational trajectory is improving, with operating losses compressing by 74% and direct-to-consumer growth accelerating. The shift toward licensing and the strategic restructuring of the China business represent a clear attempt to decouple the brand's value from the risks of direct operational ownership.
However, the financial bridge to sustained GAAP profitability remains fragile. The tension between rising Adjusted EBITDA and negative operating cash flow suggests that while the 'engine' is improving, the weight of historical debt and new joint venture obligations continues to drain liquidity. The upcoming June 2026 covenant test will serve as the primary catalyst for the stock, determining whether the capital-light strategy has provided enough runway to satisfy lenders.